AUPH - (Aurinia Pharmaceuticals Inc)

 AUPHのチャート


 AUPHの企業情報

symbol AUPH
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear ―年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/auph
adr_tso
EBITDA EBITDA ー
終値(lastsale) 6.1601
時価総額(marketcap) 525599241.0367
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 AUPHのテクニカル分析


 AUPHのニュース

   Victoria’s Aurinia Pharmaceuticals days away from learning if it can take lupus drug to market  2021/01/17 22:33:30 The Globe and Mail
Until recently there was no FDA-approved drug to treat Lupus, a chronic disease that prompts the immune system to attack the body’s organs
   STAT+: Aurinia in ‘show-me phase’ as FDA nears approval decision on autoimmune kidney disease drug  2021/01/15 09:35:27 STAT News
Aurinia Pharmaceuticals is in a "show-me phase" as the FDA nears an approval decision on its drug for lupus nephritis, a serious autoimmune kidney disease.
   Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences  2021/01/08 11:05:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences and participate in a panel discussion hosted by Dr. Scott Gottlieb, former FDA Commissioner: H.C. Wainwright Virtual BioConnect 2021 Conference. On-demand fireside chat available beginning Monday, January 11, 2021 at 6:00 a.m. EST; Scott Gottlieb, M.D. Hosts a Panel Di
   My Top Six 2020 Stock Picks Gained an Average of 75%  2020/12/30 16:08:07 The Street RealMoney
A few of these names continue to look good in 2021….AUPH
   H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals  2020/12/16 17:55:03 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals
   Victoria’s Aurinia Pharmaceuticals days away from learning if it can take lupus drug to market  2021/01/17 22:33:30 The Globe and Mail
Until recently there was no FDA-approved drug to treat Lupus, a chronic disease that prompts the immune system to attack the body’s organs
   STAT+: Aurinia in ‘show-me phase’ as FDA nears approval decision on autoimmune kidney disease drug  2021/01/15 09:35:27 STAT News
Aurinia Pharmaceuticals is in a "show-me phase" as the FDA nears an approval decision on its drug for lupus nephritis, a serious autoimmune kidney disease.
   Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences  2021/01/08 11:05:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences and participate in a panel discussion hosted by Dr. Scott Gottlieb, former FDA Commissioner: H.C. Wainwright Virtual BioConnect 2021 Conference. On-demand fireside chat available beginning Monday, January 11, 2021 at 6:00 a.m. EST; Scott Gottlieb, M.D. Hosts a Panel Di
   My Top Six 2020 Stock Picks Gained an Average of 75%  2020/12/30 16:08:07 The Street RealMoney
A few of these names continue to look good in 2021….AUPH
   H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals  2020/12/16 17:55:03 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals
   My Top Six 2020 Stock Picks Gained an Average of 75%  2020/12/30 16:08:07 The Street RealMoney
A few of these names continue to look good in 2021….AUPH
   H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals  2020/12/16 17:55:03 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals
   Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity  2020/12/15 22:59:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia”) and Lonza Ltd. (SIX: LONN) ("Lonza") today announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp, Switzerland. The dedicated facility (also referred to as "monoplant") will be equipped with state-of-the-art manufa
   Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference  2020/12/02 11:05:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site through December 3. In order to listen to the audio webcast, interested parties can register and access the live webcast under "News/Events” through the “Investors” section of the Aurinia co
   Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference  2020/11/12 21:05:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the senior management team will participate in a fireside chat during the 2020 Jefferies Virtual London Healthcare Conference on November 19, 2020 at 11:25 a.m. ET. In order to participate in the audio webcast, interested parties can register and access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporate web

 関連キーワード  (― 米国株 AUPH Aurinia Pharmaceuticals Inc)

 twitter  (公式ツイッターやCEOツイッターなど)